Department of general and visceral surgery, Klinikum Oldenburg, Rahel-Strauss-Str. 10, 26133 Oldenburg, Germany.
J Visc Surg. 2013 Dec;150(6):379-82. doi: 10.1016/j.jviscsurg.2013.08.002. Epub 2013 Oct 18.
Rectovaginal fistulas constitute a serious burden for the affected patient and a major challenge for the attending surgeon. Definitive surgical treatment of the fistula depends on the size and location of the fistula, the underlying disease, and any previous therapies. In regards to complicated recurrent rectovaginal fistulas, transposition of the gracilis muscle is one of the well-established therapeutic options with a success rate of up to 70%.
Between 01/2004 and 06/2010, ten patients diagnosed with a recurrent rectovaginal fistula were treated in the surgical department of Klinikum Oldenburg by gracilis muscle transposition; their data were collected and analyzed. Post-operative evaluation was performed using a standardized telephone interview. All patients had a protective stoma. The primary endpoint of assessment was the long-term healing of the fistula following stoma reversal, and the comparison between those who were treated successfully versus those who were not.
Over a time span of 6years, ten women with a complicated rectovaginal fistula underwent fistula repair with the gracilis muscle transposition. Patient age ranged from 29 and 64years. There were five rectovaginal fistulas, four pouch-vaginal fistulas, and one anovaginal fistula. The underlying disease was rectal cancer in seven patients, Crohn's disease in one patient, previous complicated gynecologic surgery in one patient, and idiopathic anal fistula in one patient. All seven patients with rectal cancer underwent radiochemotherapy with 50.4Gy (n=6 neo-adjuvant, n=1 adjuvant). All ten patients had previously undergone repair by a different surgical approach while five presented with a second or third recurrence. Post-operative complications were noted in two patients (perineal wound defect, thigh hematoma). Follow-up of the patients ranged from 8 to 60months. Recurrent rectovaginal fistula occurred in four patients. Evaluation of the data failed to identify statistically significant criteria for treatment failure of rectovaginal fistula repair.
Our results are similar to previous studies in this area. For the majority of the patients, the gracilis muscle transposition was a long-term effective treatment of recurrent rectovaginal fistulas, however recurrences were noted in 40% of cases. Predictive criteria for treatment failure could not be established.
直肠阴道瘘给患者带来严重的负担,也是主治医生面临的重大挑战。瘘管的确定性治疗取决于瘘管的大小和位置、潜在疾病以及任何先前的治疗。对于复杂的复发性直肠阴道瘘,腹直肌转位是一种成熟的治疗选择,成功率高达 70%。
2004 年 1 月至 2010 年 6 月,10 例在奥尔登堡 Klinikum 外科诊断为复发性直肠阴道瘘的患者接受了腹直肌转位治疗;收集并分析了他们的数据。术后评估采用标准化电话访谈进行。所有患者均行保护性造口术。评估的主要终点是造口回纳后瘘管的长期愈合情况,并比较成功治疗与未成功治疗的患者。
在 6 年的时间里,10 例复杂直肠阴道瘘患者接受了腹直肌转位修复瘘管。患者年龄 29 至 64 岁。其中 5 例为直肠阴道瘘,4 例为直肠阴道袋瘘,1 例为阴道直肠瘘。7 例患者的基础疾病为直肠癌,1 例为克罗恩病,1 例为既往复杂妇科手术,1 例为特发性肛门瘘。7 例直肠癌患者均接受了 50.4Gy 的放化疗(6 例新辅助,1 例辅助)。10 例患者均曾接受过不同手术方法的修复,其中 5 例为第二次或第三次复发。2 例患者(会阴伤口缺损,大腿血肿)出现术后并发症。患者的随访时间为 8 至 60 个月。4 例患者出现复发性直肠阴道瘘。对数据的评估未能确定直肠阴道瘘修复治疗失败的统计学显著标准。
我们的结果与该领域的先前研究相似。对于大多数患者,腹直肌转位是复发性直肠阴道瘘的长期有效治疗方法,但有 40%的病例出现复发。未能确定治疗失败的预测标准。